|
시장보고서
상품코드
1888647
동물 모델 시장 규모, 점유율, 동향 분석 보고서 : 동물 유형별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)Animal Model Market Size, Share & Trends Analysis Report By Animal Type (Mice, Guinea Pigs), By Application (Cancer, Infectious Disease), By End Use, By Region, And Segment Forecasts, 2025 - 2033 |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
동물 모델 시장 요약
세계의 동물 모델 시장 규모는 2024년에 24억 2,000만 달러로 추정되며, 2033년까지 51억 8,000만 달러에 달할 것으로 예측됩니다.
2025년부터 2033년까지 CAGR 8.94%로 성장할 것으로 예상됩니다. 생의학, 신경학, 유전학, 독성학 및 암 연구에서 동물 모델의 활용이 확대되면서 세계 시장 성장을 주도하고 있습니다.
또한, 신규 치료제 개발을 위한 바이오제약 기업들의 연구개발 활동의 활성화와 CRISPR 등 첨단 기술의 바이오메디컬 연구 분야로의 도입도 산업 확대에 기여하는 요인으로 작용하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 시장 변수, 동향 및 범위
- 시장 계통 전망
- 상부 시장 전망
- 관련·부수 시장 전망
- 시장 역학
- 업계 분석 툴
- Porter's Five Forces 분석
- PESTEL 분석
제4장 동물 유형별 비즈니스 분석
- 동물 모델 시장 : 동물 유형별 변동 분석
- 마우스
- 마우스 시장, 2021-2033년
- 래트
- 래트 시장, 2021-2033년
- 몰모트
- 몰모트 시장, 2021-2033년
- 토끼
- 토끼 시장, 2021-2033년
- 햄스터
- 햄스터 시장, 2021-2033년
- 기타
- 기타 시장, 2021-2033년
제5장 용도별 비즈니스 분석
- 동물 모델 시장 : 용도별 변동 분석
- 암
- 암 시장, 2021-2033년
- 면역질환
- 면역질환 시장, 2021-2033년
- 감염증
- 감염증 시장, 2021-2033년
- 기타
- 기타 시장, 2021-2033년
제6장 최종 용도별 비즈니스 분석
- 동물 모델 시장 : 최종 용도 변동 분석
- 제약·바이오테크놀러지 기업
- 제약·바이오테크놀러지 기업 시장, 2021-2033년
- 학술연구기관
- 학술연구기관 시장, 2021-2033년
- CRO(수탁연구기관)
- CRO(수탁연구기관) 시장, 2021-2033년
제7장 지역별 비즈니스 분석
- 동물 모델 시장 점유율(지역별), 2024년 및 2033년
- 북미
- 북미의 동물 모델 시장, 2021-2033년
- 미국
- 캐나다
- 멕시코
- 유럽
- 유럽의 동물 모델 시장, 2021-2033년
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
- 아시아태평양
- 아시아태평양의 동물 모델 시장, 2021-2033년
- 일본
- 중국
- 인도
- 호주
- 태국
- 한국
- 라틴아메리카
- 라틴아메리카의 동물 모델 시장, 2021-2033년
- 브라질
- 아르헨티나
- 중동 및 아프리카
- 중동 및 아프리카(MEA) 동물 모델 시장, 2021-2033년
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트
제8장 경쟁 구도
- 기업 분류
- 전략 매핑
- 2022년의 기업 점유율 분석
- 기업 개요/리스트
- Charles River Laboratories
- The Jackson Laboratory
- genOway
- Taconic Biosciences, Inc
- Janvier Labs
- BioModels, LLC.
- Crown Bioscience
- Inotiv
- BIOCYTOGEN
- Hooke Laboratories
Animal Model Market Summary
The global animal model market size was estimated at USD 2.42 billion in 2024 and is projected to reach USD 5.18 billion by 2033, growing at a CAGR of 8.94% from 2025 to 2033. The increasing use of animal models in biomedical, neurological, genetic, toxicology, and cancer research is driving global market growth.
Moreover, growing R&D efforts by biopharmaceutical companies to develop novel therapeutics and the emergence of advanced technologies, such as CRISPR, in biomedical research, are other factors contributing to industry expansion.
Global Animal Model Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global animal model market based on animal type, application, end use, and region:
- Animal Type Outlook (Revenue, USD Million, 2021 - 2033)
- Mice
- Rat
- Guinea Pigs
- Rabbits
- Hamsters
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Cancer
- Immunological Disease
- Infectious Disease
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical & Biotechnology Companies
- Academic Research Institute
- Contract Research Organization
- Regional Outlook (Revenue, USD Million, 2021- 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Thailand
- South Korea
- Latin America
- Brazil
- Argentina
- Middle East and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.1.1. Segment Definitions
- 1.1.1.1. Animal Type Segment
- 1.1.1.2. Application Segment
- 1.1.1.3. End Use Segment
- 1.1.1. Segment Definitions
- 1.2. Regional Scope
- 1.3. Estimates and Forecast Timeline
- 1.4. Objective
- 1.4.1. Objective 1
- 1.4.2. Objective2
- 1.4.3. Objective 3
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.6.3. Secondary Sources
- 1.6.4. Primary Research
- 1.7. Information or Data Analysis:
- 1.7.1. Data Analysis Models
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity Flow Analysis
- 1.10. List of Secondary Sources
- 1.11. List of Abbreviations
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.1.1. Increasing Prevalence of Chronic and Lifestyle Diseases
- 3.2.1.2. Preclinical Research Needs
- 3.2.2. Market Restraint Analysis
- 3.2.2.1. High cost of process
- 3.2.2.2. Stringent rules pertaining to animal testing.
- 3.2.1. Market Driver Analysis
- 3.3. Industry Analysis Tools
- 3.3.1. Porter's Five Forces Analysis
- 3.3.2. PESTEL Analysis
Chapter 4. Animal Type Business Analysis
- 4.1. Animal Model Market: Animal Type Movement Analysis
- 4.2. Mice
- 4.2.1. Mice Market, 2021 - 2033 (USD Million)
- 4.3. Rat
- 4.3.1. Rat Market, 2021 - 2033 (USD Million)
- 4.4. Guinea Pig
- 4.4.1. Guinea Pig Market, 2021 - 2033 (USD Million)
- 4.5. Rabbits
- 4.5.1. Rabbits Market, 2021 - 2033 (USD Million)
- 4.6. Hamsters
- 4.6.1. Hamsters Market, 2021 - 2033 (USD Million)
- 4.7. Others
- 4.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 5. Application Business Analysis
- 5.1. Animal Model Market: Application Movement Analysis
- 5.2. Cancer
- 5.2.1. Cancer Market, 2021 - 2033 (USD Million)
- 5.3. Immunological Disease
- 5.3.1. Immunological Disease Market, 2021 - 2033 (USD Million)
- 5.4. Infectious Disease
- 5.4.1. Infectious Disease Market, 2021 - 2033 (USD Million)
- 5.5. Others
- 5.5.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. End Use Business Analysis
- 6.1. Animal Model Market: End Use Movement Analysis
- 6.2. Pharmaceutical & Biotechnology Companies
- 6.2.1. Pharmaceutical & Biotechnology Companies Market, 2021 - 2033 (USD Million)
- 6.3. Academic Research Institute
- 6.3.1. Academic Research Institute Market, 2021 - 2033 (USD Million)
- 6.4. Contract Research Organization
- 6.4.1. Contract Research Organization Market, 2021 - 2033 (USD Million)
Chapter 7. Regional Business Analysis
- 7.1. Animal Model Market Share By Region, 2024 & 2033
- 7.2. North America
- 7.2.1. North America Animal Model Market, 2021 - 2033 (USD Million)
- 7.2.2. U.S.
- 7.2.2.1. Key Country Dynamics
- 7.2.2.2. Competitive Scenario
- 7.2.2.3. Regulatory Framework
- 7.2.2.4. U.S. Animal Model Market, 2021 - 2033 (USD Million)
- 7.2.3. Canada
- 7.2.3.1. Key Country Dynamics
- 7.2.3.2. Competitive Scenario
- 7.2.3.3. Regulatory Framework
- 7.2.3.4. Canada Animal Model Market, 2021 - 2033 (USD Million)
- 7.2.4. Mexico
- 7.2.4.1. Key Country Dynamics
- 7.2.4.2. Competitive Scenario
- 7.2.4.3. Regulatory Framework
- 7.2.4.4. Mexico Animal Model Market, 2021 - 2033 (USD Million)
- 7.3. Europe
- 7.3.1. Europe Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.2. UK
- 7.3.2.1. Key Country Dynamics
- 7.3.2.2. Competitive Scenario
- 7.3.2.3. Regulatory Framework
- 7.3.2.4. UK Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.3. Germany
- 7.3.3.1. Key Country Dynamics
- 7.3.3.2. Competitive Scenario
- 7.3.3.3. Regulatory Framework
- 7.3.3.4. Germany Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.4. France
- 7.3.4.1. Key Country Dynamics
- 7.3.4.2. Competitive Scenario
- 7.3.4.3. Regulatory Framework
- 7.3.4.4. France Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.5. Italy
- 7.3.5.1. Key Country Dynamics
- 7.3.5.2. Competitive Scenario
- 7.3.5.3. Regulatory Framework
- 7.3.5.4. Italy Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.6. Spain
- 7.3.6.1. Key Country Dynamics
- 7.3.6.2. Competitive Scenario
- 7.3.6.3. Regulatory Framework
- 7.3.6.4. Spain Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.7. Denmark
- 7.3.7.1. Key Country Dynamics
- 7.3.7.2. Competitive Scenario
- 7.3.7.3. Regulatory Framework
- 7.3.7.4. Denmark Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.8. Sweden
- 7.3.8.1. Key Country Dynamics
- 7.3.8.2. Competitive Scenario
- 7.3.8.3. Regulatory Framework
- 7.3.8.4. Sweden Animal Model Market, 2021 - 2033 (USD Million)
- 7.3.9. Norway
- 7.3.9.1. Key Country Dynamics
- 7.3.9.2. Competitive Scenario
- 7.3.9.3. Regulatory Framework
- 7.3.9.4. Norway Animal Model Market, 2021 - 2033 (USD Million)
- 7.4. Asia Pacific
- 7.4.1. Asia Pacific Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.2. Japan
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Competitive Scenario
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Japan Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.3. China
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Competitive Scenario
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. China Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.4. India
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Competitive Scenario
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. India Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.5. Australia
- 7.4.5.1. Key Country Dynamics
- 7.4.5.2. Competitive Scenario
- 7.4.5.3. Regulatory Framework
- 7.4.5.4. Australia Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.6. Thailand
- 7.4.6.1. Key Country Dynamics
- 7.4.6.2. Competitive Scenario
- 7.4.6.3. Regulatory Framework
- 7.4.6.4. Thailand Animal Model Market, 2021 - 2033 (USD Million)
- 7.4.7. South Korea
- 7.4.7.1. Key Country Dynamics
- 7.4.7.2. Competitive Scenario
- 7.4.7.3. Regulatory Framework
- 7.4.7.4. South Korea Animal Model Market, 2021 - 2033 (USD Million)
- 7.5. Latin America
- 7.5.1. Latin America Animal Model Market, 2021 - 2033 (USD Million)
- 7.5.2. Brazil
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Competitive Scenario
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Brazil Animal Model Market, 2021 - 2033 (USD Million)
- 7.5.3. Argentina
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Competitive Scenario
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Argentina Animal Model Market, 2021 - 2033 (USD Million)
- 7.6. MEA
- 7.6.1. MEA Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.2. South Africa
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Competitive Scenario
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. South Africa Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.3. Saudi Arabia
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Competitive Scenario
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Saudi Arabia Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.4. UAE
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Competitive Scenario
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. UAE Animal Model Market, 2021 - 2033 (USD Million)
- 7.6.5. Kuwait
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Competitive Scenario
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Kuwait Animal Model Market, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Share Analysis, 2022
- 8.4. Company Profiles/Listing
- 8.4.1. Charles River Laboratories
- 8.4.1.1. Overview
- 8.4.1.2. Financial Performance
- 8.4.1.3. Product Benchmarking
- 8.4.1.4. Strategic Initiatives
- 8.4.2. The Jackson Laboratory
- 8.4.2.1. Overview
- 8.4.2.2. Financial Performance
- 8.4.2.3. Product Benchmarking
- 8.4.2.4. Strategic Initiatives
- 8.4.3. genOway
- 8.4.3.1. Overview
- 8.4.3.2. Financial Performance
- 8.4.3.3. Product Benchmarking
- 8.4.3.4. Strategic Initiatives
- 8.4.4. Taconic Biosciences, Inc
- 8.4.4.1. Overview
- 8.4.4.2. Financial Performance
- 8.4.4.3. Product Benchmarking
- 8.4.4.4. Strategic Initiatives
- 8.4.5. Janvier Labs
- 8.4.5.1. Overview
- 8.4.5.2. Financial Performance
- 8.4.5.3. Product Benchmarking
- 8.4.5.4. Strategic Initiatives
- 8.4.6. BioModels, LLC.
- 8.4.6.1. Overview
- 8.4.6.2. Financial Performance
- 8.4.6.3. Product Benchmarking
- 8.4.6.4. Strategic Initiatives
- 8.4.7. Crown Bioscience
- 8.4.7.1. Overview
- 8.4.7.2. Financial Performance
- 8.4.7.3. Product Benchmarking
- 8.4.7.4. Strategic Initiatives
- 8.4.8. Inotiv
- 8.4.8.1. Overview
- 8.4.8.2. Financial Performance
- 8.4.8.3. Product Benchmarking
- 8.4.8.4. Strategic Initiatives
- 8.4.9. BIOCYTOGEN
- 8.4.9.1. Overview
- 8.4.9.2. Financial Performance
- 8.4.9.3. Product Benchmarking
- 8.4.9.4. Strategic Initiatives
- 8.4.10. Hooke Laboratories
- 8.4.10.1. Overview
- 8.4.10.2. Financial Performance
- 8.4.10.3. Product Benchmarking
- 8.4.10.4. Strategic Initiatives
- 8.4.1. Charles River Laboratories
샘플 요청 목록